Menu
ncarol.com
  • Home
  • Business
  • Real Estate
  • Music
  • Health
  • Services
  • Beauty
  • Finance
  • Financial
ncarol.com

Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
ncarol.com/10213312

Trending...
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder
Elixia
Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.

RESEARCH TRIANGLE PARK, N.C. - ncarol.com -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.

"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.

More on ncarol.com
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder
  • VDG Virtuoso Builds Independent Label (VDG Records) and PR Infrastructure
  • TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
  • VDG Virtuoso Establishes Independent Creative Infrastructure Focused on Long-Term Artist Development
  • eJoule Inc Participates in Silicon Dragon CES 2026

"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.

About Elixia

Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.

Contact
Melinda Jackson Public Relations
***@melindajacksonpr.com


Source: Elixia

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
  • tukr box Ministries Launches Meal-Sharing Kit Partnership With Marry Me Marinara
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Elderhaus Receives 2025 Grant from The Endowment to Strengthen Services and Expand Community Impact
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Beycome Closes $2.5M Seed Round Led by InsurTech Fund
  • Tru by Hilton Columbia South Opens to Guests
  • Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
  • "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
_catLbl0 _catLbl1

Popular on ncarol.com

  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 117
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder
  • Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow
  • Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure

Similar on ncarol.com

  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • eJoule Inc Participates in Silicon Dragon CES 2026
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute